1 |
Ağagündüz D, Cocozza E, Cemali Ö, Bayazıt AD, Nanì MF, Cerqua I, Morgillo F, Saygılı SK, Berni Canani R, Amero P, Capasso R. Understanding the role of the gut microbiome in gastrointestinal cancer: A review. Front Pharmacol 2023;14:1130562. [PMID: 36762108 DOI: 10.3389/fphar.2023.1130562] [Reference Citation Analysis]
|
2 |
Zeng H, Safratowich BD, Cheng WH, Bukowski MR. Identification of oncogenic signatures in the inflammatory colon of C57BL/6 mice fed a high-fat diet. J Nutr Biochem 2023;111:109188. [PMID: 36272693 DOI: 10.1016/j.jnutbio.2022.109188] [Reference Citation Analysis]
|
3 |
Srivastava S, Dubey AK, Madaan R, Bala R, Gupta Y, Dhiman BS, Kumar S. Emergence of nutrigenomics and dietary components as a complementary therapy in cancer prevention. Environ Sci Pollut Res Int 2022;29:89853-73. [PMID: 36367649 DOI: 10.1007/s11356-022-24045-x] [Reference Citation Analysis]
|
4 |
Bellerba F, Serrano D, Johansson H, Pozzi C, Segata N, NabiNejad A, Piperni E, Gnagnarella P, Macis D, Aristarco V, Accornero CA, Manghi P, Guerrieri-Gonzaga A, Biffi R, Bottiglieri L, Trovato C, Zampino MG, Corso F, Bellocco R, Raimondi S, Rescigno M, Gandini S. Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients. Neoplasia 2022;34:100842. [PMID: 36279751 DOI: 10.1016/j.neo.2022.100842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Markelova NN, Semenova EF, Sineva ON, Sadykova VS. The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis. IJMS 2022;23:11706. [DOI: 10.3390/ijms231911706] [Reference Citation Analysis]
|
6 |
Ramos-Lopez O, Martinez JA, Milagro FI. Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease. Nutrients 2022;14:4074. [PMID: 36235725 DOI: 10.3390/nu14194074] [Reference Citation Analysis]
|
7 |
Yan S, Wang S, Wang X, Dai W, Chu J, Cheng M, Guo Z, Xu D. Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer. Front Oncol 2022;12:954329. [DOI: 10.3389/fonc.2022.954329] [Reference Citation Analysis]
|
8 |
Banerjee M. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis, and treatment response in complex diseases. Pharmacogenomics 2021. [PMID: 34842441 DOI: 10.2217/pgs-2021-0140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
9 |
Appunni S, Rubens M, Ramamoorthy V, Tonse R, Saxena A, McGranaghan P, Kaiser A, Kotecha R. Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer. Front Nutr 2021;8:718389. [PMID: 34708063 DOI: 10.3389/fnut.2021.718389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|